Dr. Joaquina Baranda, MD
Claim this profileUniversity of Kansas Clinical Research Center
Studies Cancer
Studies Pancreatic Cancer
9 reported clinical trials
14 drugs studied
Area of expertise
1Cancer
Stage IV
SETD2 positive
Stage III
2Pancreatic Cancer
Stage IV
SETD2 positive
Stage III
Affiliated Hospitals
Clinical Trials Joaquina Baranda, MD is currently running
Temozolomide + Tuvusertib
for Cancer
This trial tests a combination of two drugs, temozolomide and M1774, in patients with advanced cancer that has spread. Temozolomide damages cancer cell DNA, while M1774 blocks growth enzymes. The goal is to find a more effective treatment for these patients.
Recruiting1 award Phase 1 & 2
Metarrestin
for Advanced Cancer
Background: Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or reduces metastasis. Researchers hope a new drug can help. It stops cancer cells from growing and spreading further and possibly shrink cancer lesions in distant organs. Objective: To find a safe dose of metarrestin and to see if this dose shrinks tumors. Eligibility: Adults age 18 and older with pancreatic cancer, breast cancer, or a solid tumor that has not been cured by standard therapies. Also, children age 12-17 with a solid tumor (other than a muscle tumor) with no standard therapy options. Design: Participants will be screened with: * blood tests * physical exam * documentation of disease confirmation or tumor biopsy * electrocardiogram to evaluate the heart * review of their medicines and their ability to do their normal activities Participants will take metarrestin by mouth until they cannot tolerate it or stop to benefit from it. They will keep a medicine diary. Participants will visit the Clinical Center. During the first month there are two brief hospital stays required with visits weekly or every other week thereafter. They will repeat some of the screening tests. They will fill out questionnaires. They will have tests of their cognitive function. They will have an electroencephalogram to record brain activity. They will have a computed tomography (CT) scan or magnetic resonance imaging (MRI). A CT is a series of X-rays of the body. An MRI uses magnets and radio waves to take pictures of the body. Adult participants may have tumor biopsies. Participants will have a follow-up visit 30 days after treatment ends. Then they will have follow-up phone calls or emails every 6 months for the rest of their life or until the study ends.
Recruiting1 award Phase 1
More about Joaquina Baranda, MD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Joaquina Baranda, MD has experience with
- Atorvastatin
- ZZ06
- Metarrestin
- Adavosertib
- Nivolumab
- BAY 1895344
Breakdown of trials Joaquina Baranda, MD has run
Cancer
Pancreatic Cancer
Colorectal Cancer
Hematologic Malignancies
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joaquina Baranda, MD specialize in?
Joaquina Baranda, MD focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are SETD2 positive.
Is Joaquina Baranda, MD currently recruiting for clinical trials?
Yes, Joaquina Baranda, MD is currently recruiting for 6 clinical trials in Fairway Kansas. If you're interested in participating, you should apply.
Are there any treatments that Joaquina Baranda, MD has studied deeply?
Yes, Joaquina Baranda, MD has studied treatments such as Atorvastatin, ZZ06, Metarrestin.
What is the best way to schedule an appointment with Joaquina Baranda, MD?
Apply for one of the trials that Joaquina Baranda, MD is conducting.
What is the office address of Joaquina Baranda, MD?
The office of Joaquina Baranda, MD is located at: University of Kansas Clinical Research Center, Fairway, Kansas 66205 United States. This is the address for their practice at the University of Kansas Clinical Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.